株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

羊膜製品の世界市場 - 2025年までの予測:羊膜 (凍結保存羊膜、脱水羊膜)、羊水懸濁液

Amniotic Products Market by Type [Amniotic Membranes (Cryopreserved Amniotic Membranes, Dehydrated Amniotic Membranes), Amniotic Suspensions], Application (Wound Care, Ophthalmology, Orthopedics), End User - Global Forecast to 2025

発行 MarketsandMarkets 商品コード 936018
出版日 ページ情報 英文 127 Pages
即納可能
価格
本日の銀行送金レート: 1USD=108.53円で換算しております。
羊膜製品の世界市場 - 2025年までの予測:羊膜 (凍結保存羊膜、脱水羊膜)、羊水懸濁液 Amniotic Products Market by Type [Amniotic Membranes (Cryopreserved Amniotic Membranes, Dehydrated Amniotic Membranes), Amniotic Suspensions], Application (Wound Care, Ophthalmology, Orthopedics), End User - Global Forecast to 2025
出版日: 2020年05月07日 ページ情報: 英文 127 Pages
概要

羊膜製品の世界市場規模は、2020年の7億4800万米ドルから、2025年までに10億9500万米ドルに達し、予測期間中のCAGRで7.9%の成長が予測されています。市場の主な成長促進要因として、対象となる患者数の増加、火傷の発生率の増加、創傷治療と管理のための意識向上プログラム、ベンチャーキャピタルの資金調達と政府投資の増加などが挙げられます。新興経済国や法案 (21st Century Cures Act) の実施が、市場の企業に幅広い成長機会を提供することが期待されています。一方、羊膜の使用に関連する複雑さと制限が、市場の成長にある程度の課題をもたらすことが予想されています。

当レポートでは、羊膜製品の世界市場について調査分析し、市場概要、業界動向、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

  • 羊膜製品市場の概要
  • 羊膜市場:タイプ別
  • 羊膜製品市場:適応別
  • 羊膜製品市場:エンドユーザー別
  • 羊膜製品市場:地理的スナップショット

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 機会
    • 課題

第6章 羊膜製品市場:タイプ別

  • イントロダクション
  • 羊膜
  • 羊水懸濁液

第7章 羊膜製品市場:適応別

  • イントロダクション
  • 創傷治療
  • 整形外科
  • 眼科
  • その他

第8章 羊膜製品市場:地域別

  • イントロダクション
  • 北米
  • 欧州
  • アジア太平洋地域
  • その他の地域

第9章 競合情勢

  • 概要
  • 市場シェア分析
  • 競合シナリオ
  • 競合リーダーシップマッピング

第10章 企業プロファイル

  • MIMEDX
  • SMITH & NEPHEW
  • ORGANOGENESIS INC.
  • INTEGRA LIFESCIENCES CORPORATION
  • STRYKER CORPORATION
  • WRIGHT MEDICAL GROUP
  • APPLIED BIOLOGICS
  • CELULARITY, INC.
  • KATENA PRODUCTS, INC.
  • LUCINA BIOSCIENCES
  • NEXT BIOSCIENCES
  • SKYE BIOLOGICS INC.
  • SURGENEX
  • TISSUETECH, INC.
  • VENTRIS MEDICAL, LLC
  • STIMLABS LLC
  • VIVEX BIOLOGICS, INC.
  • LIFECELL INTERNATIONAL PVT. LTD.
  • NUVISION BIOTHERAPIES LIMITED
  • GENESIS BIOLOGICS

第11章 付録

図表

LIST OF TABLES

  • TABLE 1 GLOBAL PREVALENCE OF DIABETES
  • TABLE 2 WOUND CARE AWARENESS INITIATIVES
  • TABLE 3 FUNDING FOR REGENERATIVE MEDICINE RESEARCH BY THE NIH UNDER THE 21ST CENTURY CURES ACT
  • TABLE 4 AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 5 AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 6 AMNIOTIC MEMBRANES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 7 AMNIOTIC MEMBRANES MARKET, BY REGION, 2018-2025 (MILLION UNITS)
  • TABLE 8 NORTH AMERICA: AMNIOTIC MEMBRANES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 9 EUROPE: AMNIOTIC MEMBRANES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 10 ASIA PACIFIC: AMNIOTIC MEMBRANES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 11 CRYOPRESERVED AMNIOTIC MEMBRANES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 12 NORTH AMERICA: CRYOPRESERVED AMNIOTIC MEMBRANES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 13 EUROPE: CRYOPRESERVED AMNIOTIC MEMBRANES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 14 ASIA PACIFIC: CRYOPRESERVED AMNIOTIC MEMBRANES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 15 DEHYDRATED AMNIOTIC MEMBRANES MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 16 NORTH AMERICA: DEHYDRATED AMNIOTIC MEMBRANES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 17 EUROPE: DEHYDRATED AMNIOTIC MEMBRANES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 18 ASIA PACIFIC: DEHYDRATED AMNIOTIC MEMBRANES MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 19 AMNIOTIC SUSPENSIONS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 20 NORTH AMERICA: AMNIOTIC SUSPENSIONS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 21 EUROPE: AMNIOTIC SUSPENSIONS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 22 ASIA PACIFIC: AMNIOTIC SUSPENSIONS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 23 AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 24 AMNIOTIC PRODUCTS MARKET FOR WOUND CARE APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 25 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 26 EUROPE: AMNIOTIC PRODUCTS MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 27 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET FOR WOUND CARE APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 28 AMNIOTIC PRODUCTS MARKET FOR ORTHOPEDIC APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 29 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 30 EUROPE: AMNIOTIC PRODUCTS MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 31 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET FOR ORTHOPEDIC APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 32 AMNIOTIC PRODUCTS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 33 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 34 EUROPE: AMNIOTIC PRODUCTS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 35 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET FOR OPHTHALMOLOGY APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 36 AMNIOTIC PRODUCTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 37 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 38 EUROPE: AMNIOTIC PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 39 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 40 AMNIOTIC PRODUCTS MARKET, BY REGION, 2018-2025 (USD MILLION)
  • TABLE 41 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 42 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 43 NORTH AMERICA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 44 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 45 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 46 US: KEY MACROINDICATORS
  • TABLE 47 US: KEY MICROINDICATORS
  • TABLE 48 US: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 49 US: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 50 US: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 51 US: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 52 US: AMNIOTIC PRODUCTS MARKET FOR HOSPITALS & ASCS, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 53 CANADA: KEY MACROINDICATORS
  • TABLE 54 CANADA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 55 CANADA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 56 CANADA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 57 CANADA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 58 EUROPE: AMNIOTIC PRODUCTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 59 EUROPE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 60 EUROPE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 61 EUROPE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 62 EUROPE: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 63 UK: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 64 UK: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 65 UK: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 66 UK: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 67 GERMANY: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 68 GERMANY: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 69 GERMANY: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 70 GERMANY: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 71 FRANCE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 72 FRANCE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 73 FRANCE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 74 FRANCE: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 75 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2006 VS. 2016 (% OF GDP)
  • TABLE 76 ROE: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 77 ROE: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 78 ROE: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 79 ROE: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 80 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY COUNTRY, 2018-2025 (USD MILLION)
  • TABLE 81 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 82 ASIA PACIFIC: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 83 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 84 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 85 CHINA: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 86 CHINA: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 87 CHINA: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 88 CHINA: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 89 JAPAN: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 90 JAPAN: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 91 JAPAN: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 92 JAPAN: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 93 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 94 ROAPAC: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 95 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 96 ROAPAC: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018-2025 (USD MILLION)
  • TABLE 97 ROW: DIABETIC POPULATION, BY REGION
  • TABLE 98 ROW: AMNIOTIC PRODUCTS MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 99 ROW: AMNIOTIC MEMBRANES MARKET, BY TYPE, 2018-2025 (USD MILLION)
  • TABLE 100 ROW: AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2018-2025 (USD MILLION)
  • TABLE 101 ROW: AMNIOTIC PRODUCTS MARKET, BY END USER, 2018-2025 (USD MILLION)

LIST OF FIGURES

  • FIGURE 1 AMNIOTIC PRODUCTS MARKET
  • FIGURE 2 RESEARCH DESIGN
  • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
  • FIGURE 5 MARKET SIZE ESTIMATION FROM PARENT MARKET
  • FIGURE 6 DATA TRIANGULATION METHODOLOGY
  • FIGURE 7 AMNIOTIC PRODUCTS MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
  • FIGURE 8 AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
  • FIGURE 9 AMNIOTIC PRODUCTS MARKET, BY END USER, 2020-2025 (USD MILLION)
  • FIGURE 10 GEOGRAPHIC SNAPSHOT OF THE GLOBAL AMNIOTIC PRODUCTS MARKET
  • FIGURE 11 GROWING TARGET PATIENT POPULATION TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD
  • FIGURE 12 CRYOPRESERVED AMNIOTIC MEMBRANES TO DOMINATE THE MARKET DURING THE FORECAST PERIOD
  • FIGURE 13 WOUND CARE APPLICATIONS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2019
  • FIGURE 14 HOSPITALS & ASCS TO BE THE LARGEST END USERS OF AMNIOTIC PRODUCTS DURING THE FORECAST PERIOD
  • FIGURE 15 US TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 16 AMNIOTIC PRODUCTS MARKET: DRIVERS, OPPORTUNITIES, AND CHALLENGES
  • FIGURE 17 AMNIOTIC MEMBRANE RESEARCH PUBLICATIONS
  • FIGURE 18 NORTH AMERICA: AMNIOTIC PRODUCTS MARKET SNAPSHOT
  • FIGURE 19 ASIA PACIFIC: AMNIOTIC PRODUCTS MARKET SNAPSHOT
  • FIGURE 20 KEY PLAYERS ADOPTED ORGANIC AS WELL AS INORGANIC GROWTH STRATEGIES BETWEEN 2017 AND 2020
  • FIGURE 21 MARKET EVOLUTION FRAMEWORK
  • FIGURE 22 AMNIOTIC PRODUCTS MARKET, BY KEY PLAYER, 2018
  • FIGURE 23 MNM VENDOR DIVE COMPARISON MATRIX: AMNIOTIC PRODUCTS MARKET
  • FIGURE 24 COMPANY SNAPSHOT: MIMEDX
  • FIGURE 25 COMPANY SNAPSHOT: SMITH & NEPHEW
  • FIGURE 26 COMPANY SNAPSHOT: ORGANOGENESIS INC.
  • FIGURE 27 COMPANY SNAPSHOT: INTEGRA LIFESCIENCES (2019)
  • FIGURE 28 COMPANY SNAPSHOT: STRYKER CORPORATION
  • FIGURE 29 COMPANY SNAPSHOT: WRIGHT MEDICAL GROUP
目次
Product Code: MD 7637

"Growth in the target patient population and awareness programs for wound care treatment and management are expected to drive the overall growth of the amniotic products market."

The global amniotic products market is projected to reach USD 1,095 million by 2025 from USD 748 million in 2020, at a CAGR of 7.9%. Market growth is largely driven by factors such as growth in the target patient population, the rising incidence of burn injuries, awareness programs for wound care treatment and management, and the rise in venture capital funding and government investments. The emerging economies and the implementation of the 21st Century Cures Act are expected to provide a wide range of growth opportunities for players in the market. On the other hand, the complications and limitations associated with the use of amniotic membranes are expected to challenge market growth to a certain extent.

"The cryopreserved amniotic membranes segment is expected to dominate the market during the forecast period."

On the basis of type, amniotic membranes are categorized into cryopreserved amniotic membranes and dehydrated amniotic membranes. Both membrane types come in a variety of tissue thicknesses and sizes, depending on clinical needs. Cryopreserved amniotic membranes commanded the largest share of the global amniotic membranes market in 2019. The cryopreservation technique retains extracellular matrix components, such as growth factors, collagen, heavy-chain hyaluronic acids, and fibronectin, all of which promote anti-inflammatory effects and healing. These characteristics of cryopreserved amniotic membranes drive market growth.

"Wound care application segment to witness the highest growth in the amniotic products market during the forecast period."

Based on application, the amniotic products market is categorized into wound care, ophthalmology, orthopedics, and other applications. Wound care was the largest application segment in the amniotic products market in 2019 and is expected to grow at the highest CAGR during the forecast period. Growth in this market is largely driven by the rising prevalence of diabetic foot ulcers, venous leg ulcers, surgical & traumatic wounds, and burn injuries.

"North America to dominate the market during the forecast period."

Geographically, the amniotic products market is segmented into North America, Europe, the Asia Pacific, and the Rest of the World. In 2019, North America accounted for the largest share of the amniotic products market. The large share of this region can be attributed to the increasing geriatric population, the strong presence of key market players of amniotic products, the high prevalence of target diseases, and rising awareness about advanced treatment options.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type: Tier 1 (36%), Tier 2 (45%), and Tier 3 (19%)
  • By Designation: C-level (33%), Directors (40%), and Others (27%)
  • By Region: North America (36%), Europe (28%), Asia Pacific (19%), and the Rest of the World (17%)

List of Companies Profiled in the Report:

  • MiMedx (US)
  • Smith & Nephew (UK)
  • Organogenesis (US)
  • Integra LifeSciences Corporation (US)
  • Stryker Corporation (US)
  • Wright Medical (Netherlands)
  • Applied Biologics (US)
  • Celularity (US)
  • Katena Products (US)
  • Lucina BioSciences (US)
  • Next Biosciences (South Africa)
  • Skye Biologics (US)
  • Surgenex (US)
  • TissueTech (US)
  • Ventris Medical (US)
  • StimLabs (US)
  • VIVEX Biologics (US)
  • LifeCell International (India)
  • NuVision Biotherapies (England)
  • Genesis Biologics (US)

Research Coverage:

This report provides a detailed picture of the global amniotic products market. It aims at estimating the size and future growth potential of the market across different segments, such as type, application, end user, and region. The report also includes an in-depth competitive analysis of the key market players, along with their company profiles, recent developments, and key market strategies.

Key Benefits of Buying the Report:

The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall amniotic products market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights in order to position their businesses better and make suitable go-to-market strategies. This report will enable stakeholders to understand the pulse of the market and provide them with information on the key market drivers, restraints, opportunities, and challenges.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
  • 1.3 MARKET SCOPE
    • 1.3.1 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
  • 1.5 LIMITATIONS
  • 1.6 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
  • 2.2 SECONDARY DATA
    • 2.2.1 SECONDARY SOURCES
  • 2.3 PRIMARY DATA
    • 2.3.1 KEY DATA FROM PRIMARY SOURCES
  • 2.4 MARKET SIZE ESTIMATION
    • 2.4.1 BOTTOM-UP APPROACH
    • 2.4.2 GROWTH FORECAST
  • 2.5 MARKET BREAKDOWN AND DATA TRIANGULATION
  • 2.6 ASSUMPTIONS FOR THE STUDY

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

  • 4.1 AMNIOTIC PRODUCTS MARKET OVERVIEW
  • 4.2 AMNIOTIC MEMBRANES MARKET, BY TYPE, 2020 VS. 2025 (USD MILLION)
  • 4.3 AMNIOTIC PRODUCTS MARKET, BY APPLICATION, 2020 VS. 2025 (USD MILLION)
  • 4.4 AMNIOTIC PRODUCTS MARKET, BY END USER, 2019
  • 4.5 AMNIOTIC PRODUCTS MARKET: GEOGRAPHIC SNAPSHOT

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • 5.2.1 DRIVERS
      • 5.2.1.1 Growth in the target patient population
      • 5.2.1.2 Rising incidence of burn injuries
      • 5.2.1.3 Awareness programs for wound care treatment and management
      • 5.2.1.4 Rise in venture capital investment and government funding
    • 5.2.2 OPPORTUNITIES
      • 5.2.2.1 Emerging economies
      • 5.2.2.2 Implementation of the 21st Century Cures Act (US)
    • 5.2.3 CHALLENGES
      • 5.2.3.1 Complications and limitations associated with the use of amniotic membranes

6 AMNIOTIC PRODUCTS MARKET, BY TYPE

  • 6.1 INTRODUCTION
  • 6.2 AMNIOTIC MEMBRANES
    • 6.2.1 CRYOPRESERVED AMNIOTIC MEMBRANES
      • 6.2.1.1 Cryopreserved amniotic membranes to dominate the market during the forecast period
    • 6.2.2 DEHYDRATED AMNIOTIC MEMBRANES
      • 6.2.2.1 Logistical advantages of dehydrated amniotic membranes over cryopreserved amniotic membranes to drive market growth
  • 6.3 AMNIOTIC SUSPENSIONS
    • 6.3.1 ANTI-ADHESIVE, ANTI-INFLAMMATORY, AND ANTIMICROBIAL PROPERTIES OF AMNIOTIC SUSPENSIONS TO DRIVE GROWTH

7 AMNIOTIC PRODUCTS MARKET, BY APPLICATION

  • 7.1 INTRODUCTION
  • 7.2 WOUND CARE
    • 7.2.1 WOUND CARE APPLICATIONS TO ACCOUNT FOR THE LARGEST SHARE OF THE AMNIOTIC PRODUCTS MARKET
  • 7.3 ORTHOPEDICS
    • 7.3.1 BENEFITS OFFERED BY AMNIOTIC PRODUCTS FOR ORTHOPEDIC APPLICATIONS TO DRIVE MARKET GROWTH
  • 7.4 OPHTHALMOLOGY
    • 7.4.1 LIGHTWEIGHT, THIN, AND ELASTIC NATURE OF AMNIOTIC MEMBRANES MAKES THEM SUITABLE FOR USE IN OPHTHALMOLOGY
  • 7.5 OTHER APPLICATIONS

8 AMNIOTIC PRODUCTS MARKET, BY REGION

  • 8.1 INTRODUCTION
  • 8.2 NORTH AMERICA
    • 8.2.1 US
      • 8.2.1.1 The US to dominate the North American amniotic products market during the forecast period
    • 8.2.2 CANADA
      • 8.2.2.1 Rising prevalence of target diseases to drive market growth
  • 8.3 EUROPE
    • 8.3.1 UK
      • 8.3.1.1 The UK accounted for the largest share of the European amniotic products market in 2019
    • 8.3.2 GERMANY
      • 8.3.2.1 Increasing incidence of diabetes to drive market growth in Germany
    • 8.3.3 FRANCE
      • 8.3.3.1 Rising government support to drive the market demand for amniotic products in France
    • 8.3.4 REST OF EUROPE
  • 8.4 ASIA PACIFIC
    • 8.4.1 CHINA
      • 8.4.1.1 China to dominate the Asia Pacific market during the forecast period
    • 8.4.2 JAPAN
      • 8.4.2.1 Growing geriatric population to drive market growth in Japan
    • 8.4.3 ROAPAC
  • 8.5 ROW

9 COMPETITIVE LANDSCAPE

  • 9.1 OVERVIEW
  • 9.2 MARKET SHARE ANALYSIS, 2018
  • 9.3 COMPETITIVE SCENARIO
    • 9.3.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS
    • 9.3.2 PRODUCT LAUNCHES & APPROVALS
    • 9.3.3 EXPANSIONS
    • 9.3.4 ACQUISITIONS
  • 9.4 COMPETITIVE LEADERSHIP MAPPING (2019)
    • 9.4.1 VENDOR INCLUSION CRITERIA
    • 9.4.2 VISIONARY LEADERS
    • 9.4.3 INNOVATORS
    • 9.4.4 DYNAMIC DIFFERENTIATORS
    • 9.4.5 EMERGING COMPANIES

10 COMPANY PROFILES

(Business Overview, Products Offered, Recent Developments, MnM View)*

  • 10.1 MIMEDX
  • 10.2 SMITH & NEPHEW
  • 10.3 ORGANOGENESIS INC.
  • 10.4 INTEGRA LIFESCIENCES CORPORATION
  • 10.5 STRYKER CORPORATION
  • 10.6 WRIGHT MEDICAL GROUP
  • 10.7 APPLIED BIOLOGICS
  • 10.8 CELULARITY, INC.
  • 10.9 KATENA PRODUCTS, INC.
  • 10.10 LUCINA BIOSCIENCES
  • 10.11 NEXT BIOSCIENCES
  • 10.12 SKYE BIOLOGICS INC.
  • 10.13 SURGENEX
  • 10.14 TISSUETECH, INC.
  • 10.15 VENTRIS MEDICAL, LLC
  • 10.16 STIMLABS LLC
  • 10.17 VIVEX BIOLOGICS, INC.
  • 10.18 LIFECELL INTERNATIONAL PVT. LTD.
  • 10.19 NUVISION BIOTHERAPIES LIMITED
  • 10.20 GENESIS BIOLOGICS

Business Overview, Products Offered, Recent Developments, MnM View might not be captured in case of unlisted companies.

11 APPENDIX

  • 11.1 DISCUSSION GUIDE
  • 11.2 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 11.3 AVAILABLE CUSTOMIZATIONS
  • 11.4 RELATED REPORTS
  • 11.5 AUTHOR DETAILS